-
Sang-Hoon LeeKyung Hee Univ.Korea
-
I was born in 1973, South Korea.
I was raised, educated and live n Soul, South Korea.
Education & Academic Degrees (M.D., M.S. & Ph.D.)
Mar.1993 - Feb.1995 Premedical School, Kyung Hee University, Seoul, Korea: B.S.
Mar.1995 - Feb.1999 College of Medicine, Kyung Hee University, Seoul, Korea: M.D.
Mar.2002 - Feb.2004 Graduate School, Kyung Hee University, Seoul, Korea: M.S.
Mar.2004 - Feb.2006 Graduate School, Kyung Hee University, Seoul, Korea: Ph.D.
Postgraduate(Internship, Residency, and Fellowship)
Mar.1999 - Feb.2000 Internship, Medical Center, Kyung Hee University, Seoul, Korea
Mar.2000 – Feb.2004 Residentship of Internal Medicine, Medical Center, Kyung Hee University, Seoul, Korea
May.2004 – Feb.2006 Fellowship of Rheumatology, Medical Center, Kyung Hee University, Seoul, Korea (Tutor Prof. H.I. (Hyung-In) Yang)
Feb. 2006 – Aug. 2007 Clinical Assistant Professor of Rheumatology Hospital at GANGDONG, Kyung Hee University, Seoul, Korea
Sep.20007 – Current Professor of Rheumatology, The hospital at Gangdong, The college of Medicine, Kyung Hee University, Seoul, Korea
Feb. 2013 – Jan. 2014 Visiting Professor of Immunology, Robinson Lab, Stanford Univiersity
Professional Societies (Membership)
Korean Medical Association 1999-
Korean Association of Internal medicine 2004-
Korean College of Rheumatology 2004-
Research & Clinical FocusI have been interested in cause and mechanism of ankylosing spondylitis.
Recent my focus of Basic research is the role of TNF-alpha and IL-17 for osteogenesis
Recent my focus of clinical research is the factors of causing progression of bony ankylosis in AS
| Date | Time | Room | Session Title | Lecture Title |
|---|---|---|---|---|
| Oct 23 | 08:00-08:40 | Room C | [Breakfast Symposium VI - Lilly] Up-to-date Treatment of SpA | Ixekizumab: New treatment option for patients with axial SpA |
